Dissecting paracrine effectors for mesenchymal stem cells

Advances in Biochemical Engineering/Biotechnology

Volumn 129, Issue , 2013, Pages 137-152

  Bruno, Stefania ^a   Collino, Federica ^a   Tetta, Ciro ^a   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Acute injury; Bioactive factors; Chemokines; Conditioned medium; Growth factors; Microvesicles

Indexed keywords

ANGIOGENESIS; ANIMAL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; HUMAN; MESENCHYMAL STROMA CELL; METHODOLOGY; PARACRINE SIGNALING; PHYSIOLOGY; REGENERATIVE MEDICINE; STEM CELL;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; HUMANS; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; REGENERATIVE MEDICINE; STEM CELLS;

EID: 84882968617     PISSN: 07246145     EISSN: None     Source Type: Book Series    
DOI: 10.1007/10_2012_149     Document Type: Article

References (94)

1. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822
2. Aliotta JM, Sanchez-Guijo FM, Dooner GJ et al (2007) Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 25:2245-2256
3. Amado LC, Saliaris AP, Schuleri KH et al (2005) Cardiac repair with intramyocardial injection of allogenic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102:11474-11479
4. + cells. J Immunol 175:1483-1490
5. Bartholomew A, Sturgeon C, Siatskas M et al (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48
6. Bi B, Schmitt R, Israilova M et al (2007) Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486-2496
7. Birukova AA, Alekseeva E, Mikaelyan A et al (2007) HGF attenuates thrombin-induced endothelial permeability by Tiam1-mediated activation of the Rac pathway and by Tiam1/ Rac-dependent inhibition of the Rho pathway. FASEB J 21:2776-86
8. Breitbach M, Bostani T, Roell W et al (2007) Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110:1362-1369
9. Bruno S, Grange C, Deregibus MC et al (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067
10. Camussi G, Deregibus MC, Bruno S et al (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78:838-848
11. Caplan A, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084
12. Casiraghi F, Azzollini N, Cassis P et al (2008) Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181:3933-3946
13. Chen L, Zhang W, Yue H et al (2007) Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev 16:719-731
14. Choi S, Park M, Kim J et al (2009) The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 18:521-529
15. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43-51
16. Collino F, Deregibus MC, Bruno S et al (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 5:11803
17. Darnel JE Jr (1997) STATs and gene regulation. Science 277:1630-1635
18. Deregibus MC, Cantaluppi V, Calogero R et al (2007) Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440-2448
19. Di Ianni M, Del Papa B, De Ioanni M et al (2008) Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol 36:309-318
20. Di Nicola M, Carlo-Stella C, Magni M et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843
21. Djouad F, Charbonnier LM, Bouffi C et al (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025-2032
22. Duffield JS, Park KM, Hsiao LL et al (2005) Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743-1755
23. English K, Barry FP, Mahon BP (2008) Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 115:50-58
24. Epperly MW, Guo H, Gretton JE et al (2003) Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 29:213-224
25. Ernst M, Jenkins BJ (2004) Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet 20:23-32
26. Fang X, Neyrinck AP, Matthay MA et al (2010) Allogenic human MSC restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 285:26211-26222
27. Fazel S, Chen L, Weisel RD et al (2005) Cell transplantation preserve cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. J Thorac Cardiovasc Surg 130:1310-1318
28. Garcia-Olmo D, Garcia-Arranz M, Herreros D et al (2005) A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416-1423
29. Gatti S, Bruno S, Deregibus MC et al (2011) Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26:1474-1483
30. Ge W, Jiang J, Baroja ML et al (2009) Infusion of mesenchymal stem cells and rapamycin synergize to attenuate allo-immune responses and promote cardiac allograft tolerance. Am J Transplant 9:1760-1772
31. Glennie S, Soeiro I, Dyson PJ et al (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821-2827
32. Gnecchi M, He H, Liang OD et al (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cell. Nat Med 11:267-368
33. Gnecchi M, He H, Noiseux N et al (2006) Evidence supporting paracrine hypothesis for Aktmodified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661-669
34. Gupta N, Su X, Popov B et al (2007) Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179:1855-63
35. Hauser PV, De Fazio R, Bruno S et al (2010) Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 177:2011-2021
36. Heijnen HF, Schiel AE, Fijnheer R et al (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94:3791-3799
37. Herrera MB, Bussolati B, Bruno S et al (2004) Mesenchymal stem cells contribute to renal repair on acute tubular epithelial injury. Int J Mol Med 14:1035-1041
38. Herrera MB, Bussolati B, Bruno S et al (2007) Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 72:430-441
39. Hoek JB, Pastorino JG (2004) Cellular signalling mechanisms in alcohol-induced liver damage. Semin Liver Dis 24:257-272
40. Humphreys BD, Valerius MT, Kobayashi A et al (2008) Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 6:284-2891
41. Hwu P, Du MX, Lapointe R et al (2000) Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164:3596-3599
42. Imberti B, Morigi M, Tomasoni S et al (2007) Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18:2921-2928
43. Jang YY, Sharkis SJ (2004) Metamorphosis from bone marrow derived primitive stem cells to functional liver cells. Cell Cycle 3:980-982
44. Kim I, Moon SO, Park SK et al (2001) Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 89:477-479
45. Kinnaird T, Stabile E, Burnett MS et al (2004) Local delivery of marrow derived stromal cells augments collateral perfusion through paracrine mechanism. Circulation 109:1543-1549
46. Krampera M, Glennie S, Dyson J et al (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729
47. Kunter U, Rong S, Boor P et al (2007) Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 18:1754-1764
48. Kwak HJ, So JN, Lee SJ et al (1999) Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 448:249-253
49. Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfuaion injury. Stem Cell Res 4:214-222
50. Lai RC, Chen TS, Lim SK (2011) Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 6:481-492
51. Le Blanc K, Rasmusson I, Sundberg B et al (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441
52. Lee JW, Fang X, Gupta N et al (2009) Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A 106:16357-16362
53. Li H, Guo Z, Jiang X et al (2008) Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells 26:2531-2541
54. Li L, Zhang S, Zhang Y et al (2009) Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 36:725-731
55. Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23:445-449
56. Mei SH, McCarter SD, Deng Y et al (2007) Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4:e269
57. Meisel R, Zibert A, Laryea M et al (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621
58. Méndez-Ferrer S, Michurina TV, Ferraro F et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834
59. Mirotsou M, Zhang Z, Deb A et al (2007) Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 104:1643-1648
60. Morigi M, Imberti B, Zoja C et al (2004) Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15:1794-1804
61. Morigi M, Introna M, Imberti B et al (2008) Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26:2075-2082
62. Nemeth K, Leelahavanichkul A, Yuen PS et al (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49
63. Nemzek JA, Ebong SJ, Kim J et al (2002) Keratinocyte growth factor pretreatment is associated with decreased macrophage inflammatory protein-2a concentrations and reduced neutrophil recruitment in acid aspiration lung injury. Shock 18:501-506
64. Nishida M, Li TS, Hirata K et al (2003) Improvement of cardiac function by bone marrow cell implantation in a rat hypoperfusion heart model. Ann Thorac Surg 75:768-773
65. Ortiz LA, Gambelli F, McBride C et al (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100:8407-8411
66. Ortiz LA, Dutreil M, Fattman C et al (2007) Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 104:11002-11007
67. Parekkadan B, van Poll D, Suganuma K et al (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. Plos ONE 9:e941
68. Prevosto C, Zancolli M, Canevali P et al (2007) Genertaion of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 92:881-888
69. Popp FC, Eggenhofer E, Renner P et al (2008) Mesenchymal stem cells can induce long term acceptance of solid organ allografts in synergy with low-dose mucophenolato. Transpl Immunol 20:55-60
70. Ratajczak J, Miekus K, Kucia M et al (2006) Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:847-56
71. Ratajczak J, Wysoczynski M, Hayek F et al (2006). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:1487-1495
72. Rojas M, Xu J, Woods CR et al (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33:145-152
73. Ryan JM, Barry F, Murphy JM et al (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353-363
74. Sato K, Ozaki K, Oh I et al (2007) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228-234
75. + regulatory T cells. Stem Cells 26:212-222
76. Shabbir A, Zisa D, Suzuki G et al (2009) Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a non invasive therapeutic regimen. Am J Physiol Heart Circ Physiol 296:H1888-H1897
77. Shabbir A, Zisa D, Lin H et al (2010) Activation of host tissue trophic factors through JAKSTAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair. Am J Physiol Heart Cirs Physiol 299:H1428-H1438
78. Shi S, Gronthos S (2003) Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696-704
79. Spaggiari GM, Capobianco A, Becchetti S et al (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484-1490
80. Tetta C, Bruno S, Fonsato V et al (2011) The role of microvesicles in tissue repair. Organogenesis 7:102-115
81. Timmers L, Lim S-K, Arslan F et al (2008) Reduction of infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1:129-137
82. Tögel F, Zhang P, Hu Z et al (2009) VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med 13:2109-2114
83. Tomita S, Mickle DA, Weisel RD et al (2002) Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123:1132-1140
84. Tse WT, Pendleton JD, Beyer WM et al (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389-397
85. Van Poll D, Parekkadan B, Cho CH et al. (2008) Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47:1634-1643
86. Wang Y, Folkesson HG, Jayr C et al (1999) Alveolar epithelial fluid transport can be simultaneously upregulated by both KGF and b-agonist therapy. J Appl Physiol 87:1852-1860
87. Ware LB, Matthay MA (2002) Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 282:L924-L940
88. Xu J, Woods CR, Mora AL et al (2007) Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 293:L131-L141
89. Xu J, Qu J, Cao L et al (2008) Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol 214:472-481
90. Yagi H, Soto-Gutierrez A, Parekkadan B et al (2011) Mesenchymal stem cells: mechanism of immunomodulation and homing. Cell Transplant 19:667-679
91. Yamada M, Kubo H, Kobayashi S et al (2004) Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 72:1266-1272
92. + regulatory T cells from human peripheral blood. J Immunol 166:7282-7289
93. Yano T, Mason RJ, Pan T et al (2000) KGF regulates pulmonary epithelial proliferation and surfactant protein gene expression in adult rat lung. Am J Physiol Lung Cell Mol Physiol 279:L1146-1158
94. Yuan A, Farber EL, Rapoport AL et al (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE 4:4722